European Society for Medical Oncology
The European Society for Medical Oncology (ESMO) is the leading professional organisation for medical oncology. With 18,000 members representing oncology professionals from over 150 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide.
Founded in 1975, ESMO has European roots with a global reach. Home for all oncology stakeholders, ESMO connects professionals with diverse expertise and experience. Its education and information resources support an integrated multi-professional approach to cancer care, from a medical oncology perspective. ESMO seeks to erase boundaries in cancer care, whether between countries or specialities, and pursue its mission across oncology, worldwide.
The mission of the Society is to:
- improve the quality of prevention, diagnosis, treatment, supportive and palliative care, as well as the follow-up of patients with malignant disorders
- advance the art, science, recognition, and practice of oncology
- disseminate knowledge in oncology to cancer patients and the public
- educate and train persons involved in clinical cancer care and research
- promote education in oncology in order to ensure a high standard of qualification of medical oncologists within the multidisciplinary team
- facilitate equal access to optimal cancer care for all cancer patients
- maintain liaisons with other oncology specialties, cancer leagues, universities, patient groups and, where appropriate, the pharmaceutical industry
Annals of Oncology
Founded in 1990, ESMO’s flagship scientific journal, Annals of Oncology, publishes articles addressing medical oncology, surgery, radiotherapy, pediatric oncology, basic research and the comprehensive management of patients with malignant diseases. Annals of Oncology is the official journal of ESMO and from 2008 of the Japanese Society for Medical Oncology (JSMO)
ESMO Clinical Practice Guidelines
The ESMO Clinical Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine. Each Clinical Practice Guideline includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up designed to help oncologists deliver an appropriate quality of care to their patients.
- Breast Cancer
- Cancers of Unknown Primary Site
- Endocrine and Neuroendocrine Cancers
- ESMO Endocrine Cancers
- Gastrointestinal Cancers
- Genitourinary Cancers
- Gynaecological Cancers
- Haematological Malignancies
- Head and Neck Cancers
- Hereditary Syndromes
- Lung and Chest Tumours
- Management of anaemia and iron deficiency in patients with cancer
- Sarcoma and GIST
- Supportive and Palliative Care
The annual ESMO Congress, held every year is attended by 25,000 participants. The congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualises new findings for practical implementation in every day patient care.
Additional Continuing Medical Educational Resources
ESMO publishes handbooks, scientific meeting reports, and medical oncology training guidelines. The Society provides fellowships for research training for young oncologists, an Exam in Medical Oncology and an accreditation program for institutes providing patients with integrated supportive and palliative care. Through an online professional networking platform ESMO members collaborate, interact and share knowledge on topics of research and clinical practice.